6 results
Running out of Analgesia and Sedation Medications due to #COVID19?  Anand Swaminathan, MD has put
due to #COVID19 ... #management #covid19 ... #treatment #sarscov2 ... #criticalcare #coronavirus ... #medications #sedation
Recent studies have revealed many attractive therapeutic options, even if some of them remain to be
clinical trials #covid19 ... #sarscov2 #management ... #treatment #coronavirus ... #medications
ACEi/ARBs in COVID-19: Beneficial, Bad, or Benign?
Preclinical studies suggest ACEi/ARB use increases ACE2 expression, raising concern
ACEi/ARBs in COVID ... However, ACEi/ARB ... overactivation in COVID ... #COVID19 #SARSCOV2 ... #Coronavirus #Pathophysiology
Summary of Pharmacology for Select Proposed COVID-19 Treatments

#Pharmacology #Dosing #Table #COVID19 #Coronavirus #SARSCOV2 #Medications #JAMA
Select Proposed COVID ... -19 Treatments ... Dosing #Table #COVID19 ... #Coronavirus #SARSCOV2 ... #Medications #JAMA
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Guillain-Barre Pathophysiology ... like illnesses, COVID ... Can begin in arms ... Treatment: • Plasmapheresis ... diagnosis #management #treatment
Reported Mechanisms and Toxicity of Investigational Treatments for SARS-COV-2
Chloroquine and Hydroxychloroquine
 • Mechanisms: Interference with ligand
Investigational Treatments ... combined with certain medications ... Toxicity #Toxicology #Medications ... #SARSCOV2 #COVID19 ... #Coronavirus